1. Methylphenidate Transdermal System (Daytrana™)
- Subjects
Transdermal medication -- Licensing, certification and accreditation ,Transdermal medication -- Dosage and administration ,Methylphenidate -- Licensing, certification and accreditation ,Methylphenidate -- Dosage and administration ,Methylphenidate hydrochloride -- Licensing, certification and accreditation ,Methylphenidate hydrochloride -- Dosage and administration ,Attention-deficit hyperactivity disorder -- Drug therapy ,Health - Abstract
Pharmacology Update Methylphenidate Transdermal System (Daytrana™) By William T. Elliott, MD, FACP, and James Chan, PhD, PharmD, Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; Assistant Clinical Professor [...]
- Published
- 2006